Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
<h4>Background</h4>Antiviral drugs have been recommended as prophylaxis for the reactivation of hepatitis B virus (HBV) infection in cancer patients undergoing chemotherapy. However, screening and antiviral prophylaxis for lung cancer remain controversial because of insufficient evidence...
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Public Library of Science (PLoS)
2017-01-01
|
| 叢編: | PLoS ONE |
| 在線閱讀: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179680&type=printable |